Cargando…
The Clinical Accuracy and Risk Stratification in End of Therapy (18)F-FDG PET/CT in Burkitt Lymphoma
PURPOSE: Burkitt lymphoma (BL) is an invasive lymphoma subtype with FDG avid at (18)F-FDG PET/CT, but there is currently no validated criterion in treatment evaluation and prognosis prediction. The aim of this study was to analyze the clinical accuracy of (18)F-FDG PET/CT in Burkitt lymphoma in end...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098980/ https://www.ncbi.nlm.nih.gov/pubmed/33968725 http://dx.doi.org/10.3389/fonc.2021.625436 |